Conceptus Phase III STOP Trial Designed To Show Clinical And Cost Benefit
This article was originally published in The Gray Sheet
Executive Summary
Conceptus intends to secure third-party reimbursement by examining cost-effectiveness endpoints as a part of Phase III pivotal studies of the firm's STOP non-surgical permanent female contraceptive device.